AlbionVC backed the seed round alongside PROfounders Capital, Ascension, and Emerge to support platform development.
"HR teams are stuck in a cycle of manual admin and legacy tools are failing them. They are forced to choose between clunky ticketing systems that employees hate, or basic chatbots that can’t actually get work done. We built Kinfolk to break this cycle. By shifting from manual coordination to autonomous execution, we let HR teams scale their operations and focus on the strategic work that actually drives company growth. We’re excited to give People teams the operating system they deserve, one that actually performs work instead of just managing it."
The funding round includes participation from JamJar Investments, Cur8 Capital, Energy Mix Ventures, Project Ventures, and angel investor Vlad Yatsenko.
"Having the backing of some of the UK’s most respected investors, including JamJar and a founder of one of Britain’s most successful tech companies, is a powerful validation of our team, our mission, and the product we’ve built. We’re not just optimising energy; we’re creating a more intelligent, sustainable and user-centred way of living."
ARCH Venture Partners led the oversubscribed round alongside participation from +ND Capital, OMX Ventures, and Meltwind.
"Syndex Bio’s mcPCR platform makes amplifying DNA methylation possible for the first time. This powerful method will redefine the sensitivity and accuracy that is achievable in DNA methylation analysis, opening new possibilities for early detection and disease monitoring."
The funding round was led by SFC Capital to support expansion into NHS England trusts.
"Pontiro was built inside the NHS, alongside the teams who use it every day. That matters. With this investment, we’re taking infrastructure that already works at scale in Wales and making it available to trusts across the country who are navigating the same challenges."
The financing round was led by KB Partners alongside Koppenberg Management, Match Ventures, and private syndicates.
"This round allows us to scale what we know already works. We have strong consumer demand, proven technology, and growing adoption among professionals. These fresh funds will help us expand into new international markets, business models, and sports beyond basketball. Our new investors share our vision and understand how big the demand for our technology is, and we are ready to scale at speed,"
.png)
